Mar 07, 2023 / 05:50PM GMT
Lindon G. Robertson - Azenta, Inc. - Executive VP & CFO
Hello, good afternoon, and welcome again to another Cowen conference presentation I'm Lindon Robertson, the CFO of Azenta. And with me today, I have Vandana Sriram, our Senior VP of Finance. We're really pleased to have your attention and be here at the conference.
To tell you a little bit about Azenta Life Sciences, we're into our second fiscal year of existence after separating in an unusual transformation for a company coming out of a semiconductor manufacturing automation company. In that context, we're unusual. Let me tell you a little bit about that. Before I do, of course, I should call attention to the safe harbor statement. We will make some forward-looking comments. We won't be obligated to update those. You can look at the risk factors that we've highlighted in our filings recently.
In the discussion, we'll use non-GAAP measures, of course, but we'll always encourage you to reference GAAP measures to take those into consideration in the full context of all of our discussions. So what makes us unusual as a Life Science
Azenta Inc at Cowen Health Care Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot